PAPER
Peracetylated b-Allyl C-Glycosides
EI-MS: m/z (%) = 242 (1, [M]+).
1839
3J4¢,5¢a = 9.8 Hz, 1 H, H-4¢), 3.93 (dd, 2J5¢a,5¢b = 11.0 Hz, 1 H, H-5¢a),
4.17 (dd, 3J4¢,5¢b = 4.0 Hz, 1 H, H-5¢b), 4.24 (dd, 3J2¢,3¢ = 1.6 Hz, 1 H,
H-2¢), 4.92 (dd, 3J3¢,4¢ = 3.5 Hz, 1 H, H-3¢), 5.10–5.27 (m, 2 H, H-1),
5.80 (m, 1 H, H-2).
Anal. Calcd for C12H18O5 (242.27): C, 59.49; H, 7.49. Found: C,
59.44; H, 7.71.
13C NMR (75.5 MHz, CDCl3): d = 12.4, 13.1, 13.4, 13.6
[4 × CH(CH3)2], 16.9, 17.0, 17.0, 17.2, 17.4 (two signals are iso-
chronic), 17.5, 17.5 [8 × CH(CH3)2], 38.6 (C-2¢), 41.2 (C-3), 65.6
(C-5¢), 78.9 (C-1¢), 87.3 (C-4¢), 84.4 (C-3¢), 118.0 (C-1), 133.3 (C-2).
O-Acetates 14 and 15
Freshly distilled Ac2O (25 mL) was added at 0 °C to a stirred soln
of D-ribose (4.5 g, 30.0 mmol) or D-deoxyribose in anhyd pyridine
(50 mL). After stirring for 12 h at r.t., the reaction mixture was
poured into ice-water (100 mL). The aqueous layer was extracted
with CH2Cl2 (3 × 120 mL) and the combined organic layers were
washed successively with aq 3% HCl (100 mL), ice-water (100
mL), aq sat. NaHCO3 (100 mL) and ice-water (100 mL), dried, and
concentrated.
ESI-MS (+): m/z = 527 [M + H]+.
Anal. Calcd for C20H39IO4Si2 (526.60): C, 45.62; H, 7.46. Found: C,
45.53; H, 7.51.
3-[2-Deoxy-3,5-O-(tetraisopropyldisiloxane-1,3-diyl)-b-D-
erythro-pentofuranosyl]prop-1-ene (11)
3-(2,3,4-Tri-O-acetyl-a-D-ribopyranosyl)prop-1-ene (16)
A mixture of compound 10 (790 mg, 1.5 mmol), Bu3SnH (873 mg,
3,0 mmol), and azobisisobutyronitrile (AIBN, 49 mg, 0.3 mmol) in
toluene (20 mL) was stirred under reflux for 5 h, after which addi-
tional Bu3SnH (437 mg, 1,5 mmol) and AIBN (49 mg, 0.3 mmol)
were added. Stirring under reflux was continued for further 5 h, and
the reaction mixture was then concentrated. Purification by flash
chromatography (solvent A7) afforded compound 11 (421 mg, 70%)
as a colorless syrup; [a]D23 –13.2 (c 1.0, CH2Cl2); Rf = 0.27 (solvent
A6).
TMSOTf (1.89 g, 8.5 mmol) was added dropwise to a soln of
1,2,3,4-tetra-O-acetyl-D-ribose (mixture of 14f and 14p, 2.23 g, 7.0
mmol) and allyltrimethylsilane (3.2 mL, 20 mmol) in anhyd MeCN
(20 mL) at 0 °C. The ice bath was removed, and the mixture was
stirred for 6 h at r.t. Cold aq sat. NaHCO3 (50 ml) was then added
and the aqueous phase was extracted with CH2Cl2 (3 × 100 mL).
The combined organic phases were washed with brine (2 × 100
mL), dried, and concentrated. Purification by flash chromatography
(solvent A2) afforded compound 16 (946 mg, 45%) as colorless
crystals. The synthesis corresponds to the procedure described in
the literature4 for the alleged preparation of compound 8; mp 80 °C
(EtOAc); [a]D23 –0.7 (c 1.0, CH2Cl2); Rf = 0.21 (solvent A2).
1H NMR (300 MHz, CDCl3): d = 0.99–1.09 [m, 28 H,
3
2
4 × CH(CH3)2], 1.81 (d‘t’, J1¢,2¢a = 3J2¢a,3¢ = 7.8 Hz, J2¢a,2¢b = 12.5
Hz, 1 H, H-2¢a), 2.00 (ddd, 3J2¢b,3¢ = 4.5 Hz, 3J1¢,2¢b = 6.6 Hz, 1 H, H-
2¢b), 2.18–2.37 (m, 2 H, H-3), 3.68–3.77 (m, 2 H, H-4¢, H-5¢a),
3.98–4.06 (m, 1 H, H-5¢b), 4.12 (m, 1 H, H-1¢), 4.36 (d‘t’,
3J2¢b,3¢ = 4.5 Hz, 3J2¢a,3¢ = 3J3¢,4¢ = 7.8 Hz, 1 H, H-3¢), 5.02–5.12 (m, 2
H, H-1), 5.80 (m, 1 H, H-2).
1H NMR (300 MHz, CDCl3): d = 1.98, 2.13, 2.15 (3 s, 9 H,
2 × COCH3), 2.18–2.27, 2.40–2.46 (2 m, 2 H, H-3), 3.53 (ddd,
3J1¢,2¢ = 1.2 Hz, 3J1¢,3b = 6.0 Hz, 3J1¢,3a = 7.8 Hz, 1 H, H-1¢), 3.68 (dd,
3
2
1 H, J4¢,5¢ax = 1.5 Hz, J5¢ax,5¢eq = 13.7 Hz, H-5¢ax), 4.11 (dd,
3J4¢,5¢eq = 1.8 Hz, 1 H, H-5¢eq), 5.05 (‘t’, 3J2¢,3¢ = 3J3¢,4¢ = 3.8 Hz, 1 H,
H-3¢), 5.05–5.10 (m, 2 H, H-1), 5.15 (m, 1 H, H-4¢), 5.21 (m, 1 H,
H-2¢), 5.75 (m, 1 H, H-2).
13C NMR (75.5 MHz, CDCl3): d = 12.6, 12.9, 13.4, 13.5
[4 × CH(CH3)2], 17.0, 17.0, 17.1, 17.3, 17.4, 17.4 (two signals are
isochronic), 17.5 [8 × CH(CH3)2], 39.7 (C-2¢), 39.8 (C-3), 63.8 (C-
5¢), 73.5 (C-3¢), 76.9 (C-1¢), 85.9 (C-4¢), 117.2 (C-1), 134.3 (C-2).
13C NMR (75.5 MHz, CDCl3): d = 20.6, 20.7, 21.0 (3 × COCH3),
35.4 (C-3), 66.7 (C-4¢), 67.8 (C-2¢), 68.3 (C-3¢), 69.0 (C-5¢), 77.5
(C-1¢), 118.3 (C-1), 132.9 (C-2), 169.8, 170.3, 170.4 (3 × C=O).
ESI-MS (+): m/z = 401 [M + H]+.
Anal. Calcd for C20H40O4Si2 (400.70): C, 59.95; H, 10.06. Found:
C, 60.03; H, 9.81.
CI-MS: m/z (%) = 301 (100, [M + H]+).
Anal. Calcd for C14H20O7 (300.30): C, 55.99; H, 6.71. Found: C,
56.26; H 6.78.
3-(2-Deoxy-3,5-di-O-acetyl-b-D-erythro-pentofuranosyl)prop-1-
ene (13)
A soln of TBAF in 1,4-dioxane (1.0 M, 0.4 mL) was added drop-
wise to a soln of compound 11 (100 mg, 0.25 mmol) in 1,4-dioxane
(3.0 mL) at r.t. The reaction mixture was stirred at r.t. for 5 h, and
then concentrated. The residue (compound 12) was dissolved in an-
hyd pyridine (0.5 mL) and freshly distilled Ac2O (0.25 mL) was
added, and the obtained soln was stirred overnight at r.t.. The mix-
ture was then poured into ice-water (20 mL), the aqueous phase was
extracted with CH2Cl2 (3 × 15 mL), and the combined organic phas-
es were washed successively with cold aq NaHCO3 (2 × 15 mL),
H2O (15 mL), aq 1 M HCl (2 × 15 mL), H2O (2 × 15 mL), dried, and
concentrated. Purification by flash chromatography (solvent A2) af-
3-(a-D-Ribopyranosyl)prop-1-ene (17)
Methanolic NaOMe (0.5 M, 0.15 mL) was added to a soln of com-
pound 16 (905 mg, 3.0 mmol) in anhyd MeOH (7 mL). After stir-
ring at r.t. for 2 h, the reaction mixture was neutralized with IR 120
(H+) Amberlite resign, filtered, dried, and concentrated. Flash chro-
matography (solvent B) of the residue provided compound 17 (525
24
mg, 98%) as colorless crystals; mp 155 °C; [a]D –11.8 (c 1.0,
CH3OH); Rf = 0.29 (solvent B).
1H NMR (300 MHz, DMSO-d6): d = 2.27 (m, 2 H, H-3), 3.22 (ddd,
3J1¢,2¢ = 1.1 Hz, 3J1¢,3b = 6.2 Hz, 3J1¢,3a = 7.5 Hz, 1 H, H-1¢), 3.37 (dd,
3J4¢,5¢ax = 1.0 Hz, 2J5¢ax,5¢eq = 12.0 Hz, 1 H, H-5¢ax), 3.41 (br, 1 H, H-
3¢), 3.47 (m, 1 H, H-2¢), 3.60 (br, 1 H, H-4¢), 3.75 (dd, 3J4¢,5¢eq = 2.2
Hz, 1 H, H-5¢eq), 4.59 (d, 3J2¢,OH = 7.5 Hz, 1 H, OH-2¢), 4.88 (br s,
1 H, OH-3¢), 4.97–5.09 (m, 2 H, H-1), 5.06 (br d, 3J4¢,OH = 6.2 Hz, 1
H, OH-4¢), 5.78 (m, 1 H, H-2).
13C NMR (62.9 MHz, DMSO-d6): d = 35.5 (C-3), 68.7 (C-3¢), 69.3
(C-4¢), 70.6 (C-5¢), 70.9 (C-2¢), 78.2 (C-1¢), 116.7 (C-1), 135.4 (C-
2).
22
forded compound 13 (50 mg, 83%) as a colorless syrup; [a]D
+27.9 (c 0.9, CH2Cl2); Rf = 0.22 (solvent A2).
3
1H NMR (250 MHz, CDCl3): d = 1.79 (ddd, J2¢a,3¢ = 6.4 Hz,
2
3J1¢,2¢a = 10.4 Hz, J2¢a,2¢b = 13.7 Hz, 1 H, H-2¢a), 1.99 (ddd,
3
3J2¢b,3¢ = 1.5 Hz, J1¢,2¢b = 5.2 Hz, 1 H, H-2¢b), 2.04, 2.06 (2 s, 6 H,
2 × COCH3), 2.22–2.47 (m, 2 H, H-3), 4.01–4.25 (m, 4 H, H-1¢, H-
4¢, H-5¢), 5.04–5.14 (m, 3 H, H-1, H-3¢), 5.78 (m, 1 H, H-2).
13C NMR (62.9 MHz, CDCl3): d = 20.8, 21.0 (2 × COCH3), 37.5,
39.1 (C-2¢, C-3), 64.4 (C-5¢), 76.3 (C-3¢), 78.3 (C-4¢), 82.1 (C-1¢),
117.5 (C-1), 133.8 (C-2), 170.5, 170.7 (2 × C=O).
CI-MS: m/z (%) = 197 (100, [M + Na]+).
Anal Calcd for C8H14O4 (174.19): C, 55.16; H, 8.10. Found: C,
55.39; H 8.37.
Synthesis 2009, No. 11, 1834–1840 © Thieme Stuttgart · New York